Intriguingly, this measurement is consistent with a model of A1 affinity regulation based on A1 and A1–GPIbα crystal structures, and the localization of von Willebrand disease gain of function mutations in the A1 domain near its long-range disulfide bond5–7. This evidence concerns the gene GP1BA and platelet-type von Willebrand disease.